Inactivation during phagocytosis of leucine aminopeptidase, an ecto-enzyme of polymorphonuclear neutrophils.
Changes in enzyme activities of the plasma membrane markers were examined during phagocytosis using guinea-pig polymorphonuclear neutrophils. Incubation of neutrophils with fresh serum-opsonized zymosan particles showed a significant reduction in leucine aminopeptidase activity, whereas 5'-nucleotidase and alkaline phosphodiesterase activities remained unchanged. Inactivation of leucine aminopeptidase activity was also observed by exposure of neutrophils to complement-opsonized zymosan particles, but not to non-opsonized zymosan, IgG-coated zymosan or polystyrene latex particles. Pretreatment of neutrophils with cytochalasin B, which prevents phagocytosis but not surface binding of particles, provoked inactivation to the same degree as when the cells were allowed to phagocytose the particles. However, the inactivation during phagocytosis was protected by serine protease inhibitors. These findings suggest that loss of leucine aminopeptidase activity from phagocytosing cells may be mediated by certain serine protease inhibitor-sensitive factor(s) which are probably activated by the attachment of an opsonized zymosan particle to a specific membrane receptor, probably the C3b receptor.
D000818:Animals; D002462:Cell Membrane / Q000201:enzymology; D003571:Cytochalasin B / Q000494:pharmacology; D006168:Guinea Pigs; D007931:Leucyl Aminopeptidase / Q000037:antagonists & inhibitors / Q000097:blood*; D009504:Neutrophils / Q000201:enzymology* / Q000502:physiology; D009895:Opsonin Proteins; D010587:Phagocytosis; D011137:Polystyrenes; D011480:Protease Inhibitors / Q000494:pharmacology; D015054:Zymosan
D009895:Opsonin Proteins; D011137:Polystyrenes; D011480:Protease Inhibitors; D003571:Cytochalasin B; D015054:Zymosan; D007931:Leucyl Aminopeptidase